Bruker Corp (BRKR)
82.20
-0.26
(-0.32%)
USD |
NASDAQ |
Apr 24, 16:00
82.19
-0.01
(-0.01%)
Pre-Market: 20:00
Bruker Research and Development Expense (Quarterly): 83.50M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 83.50M |
| September 30, 2023 | 71.30M |
| June 30, 2023 | 71.00M |
| March 31, 2023 | 69.00M |
| December 31, 2022 | 63.50M |
| September 30, 2022 | 56.20M |
| June 30, 2022 | 59.60M |
| March 31, 2022 | 56.60M |
| December 31, 2021 | 58.10M |
| September 30, 2021 | 52.10M |
| June 30, 2021 | 55.80M |
| March 31, 2021 | 54.80M |
| December 31, 2020 | 57.10M |
| September 30, 2020 | 48.30M |
| June 30, 2020 | 44.10M |
| March 31, 2020 | 48.50M |
| December 31, 2019 | 46.70M |
| September 30, 2019 | 46.10M |
| June 30, 2019 | 48.50M |
| March 31, 2019 | 46.40M |
| December 31, 2018 | 44.80M |
| September 30, 2018 | 41.80M |
| June 30, 2018 | 43.60M |
| March 31, 2018 | 43.20M |
| December 31, 2017 | 43.10M |
| Date | Value |
|---|---|
| September 30, 2017 | 40.60M |
| June 30, 2017 | 40.30M |
| March 31, 2017 | 37.60M |
| December 31, 2016 | 37.10M |
| September 30, 2016 | 37.90M |
| June 30, 2016 | 36.80M |
| March 31, 2016 | 36.10M |
| December 31, 2015 | 36.70M |
| September 30, 2015 | 34.30M |
| June 30, 2015 | 37.50M |
| March 31, 2015 | 37.20M |
| December 31, 2014 | 41.60M |
| September 30, 2014 | 42.10M |
| June 30, 2014 | 44.50M |
| March 31, 2014 | 46.00M |
| December 31, 2013 | 49.10M |
| September 30, 2013 | 45.50M |
| June 30, 2013 | 46.50M |
| March 31, 2013 | 49.40M |
| December 31, 2012 | 50.30M |
| September 30, 2012 | 44.90M |
| June 30, 2012 | 51.90M |
| March 31, 2012 | 48.20M |
| December 31, 2011 | 44.70M |
| September 30, 2011 | 43.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
44.10M
Minimum
Jun 2020
83.50M
Maximum
Dec 2023
57.41M
Average
56.20M
Median
Sep 2022
Research and Development Expense (Quarterly) Benchmarks
| Azenta Inc | 8.493M |
| Harvard Bioscience Inc | 3.15M |
| Bionano Genomics Inc | 11.70M |
| Akoya Biosciences Inc | 4.67M |
| Singular Genomics Systems Inc | 11.69M |